The Hospitalization-Related Costs of Adverse Events for Novel Androgen Receptor Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: An Indirect Comparison.
Adv Ther
; 39(11): 5025-5042, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-36028656
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms, Castration-Resistant
/
Hypertension
Type of study:
Clinical_trials
/
Health_economic_evaluation
Limits:
Humans
/
Male
Language:
En
Journal:
Adv Ther
Journal subject:
TERAPEUTICA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: